Short Summary

ColombianBreeD / Breedco is dedicated to the cultivation, processing and sale of medical cannabis derivatives and offers an estimated Return on Investment of 400% within the first three years in dividend payments alone.


Investment Raised
Previous Rounds €1,700,000
Stage Achieving Sales
Investor Role Any


  • One of only 8 Colombian cannabis companies with an active bank account.
  • Colombian Agreements with Canada and EU include 0% cannabis import tariffs.
  • Letters of Intent in place for up to €40 million in pre-orders.
  • Extensive expertise including preeminent leading industry figures.
  • Completed architectural & engineering plans for a GMP laboratory.
Please note: The content of this promotion has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000. Reliance on this promotion for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Global Pro
37% raised

Employee Mental Health

location_on London, United Kingdom

Tlero; a clinically backed platform to empower people & improve their mental health in the workplace; trusted by the world's best businesses; Won 'People's Choice Award' at BT Better World Challenge(2018); Already raised £150k+

450.000 €


34.000 €

Min per Investor

30% raised

Enertor Insoles

location_on East Anglia, United Kingdom

Enertor Insoles; A global specialist in orthotics & underfoot technology; Agreement with UK sports for £10m+ (5-year contract); 10-year endorsement deal with Usain Bolt; Lloyds (1500 stores) & JD Sports (600 stores) interested; Already raised £150k+...

560.000 €


1.100 €

Min per Investor

Global Pro
18% raised

Inhalable cannabis & CBD

location_on London, United Kingdom

hapac® is a unique patent pending system for vaporising medical cannabis and CBD. It also has the potential to be the lowest-cost cannabis product in the market due to its high-speed automated production and low variable costs.

910.000 €


22.000 €

Min per Investor

load one similar proposal